![Mahesh Nathalal Shah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mahesh Nathalal Shah
Nessuna posizione attualmente
Storia della carriera di Mahesh Nathalal Shah
Precedenti posizioni note di Mahesh Nathalal Shah
Società | Posizione | Inizio | Fine |
---|---|---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Direttore/Membro del Consiglio | 11/12/1999 | - |
Direttore Tecnico/Scientifico/R&S | 11/12/1999 | - |
Formazione di Mahesh Nathalal Shah
University of Mumbai | Undergraduate Degree |
Gujarat University | Graduate Degree |
Statistiche
Distribuzione geografica
India | 4 |
Posizioni
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Borsa valori
- Insiders
- Mahesh Nathalal Shah
- Esperienza